Atlas Trials

Vor Biopharma

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Vor Biopharma

RecordFirmDate
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (NCT07404865)Vor Biopharma2026-02-26
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2) (NCT06456567)Vor Biopharma2024-09-01
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) (NCT06456580)Vor Biopharma2024-07-17
Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant (NCT05984199)Vor Biopharma2023-12-11
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1) (NCT05306574)Vor Biopharma2022-06-20
A Long-term Follow-up Study of Patients Who Received VOR33 (NCT05309733)Vor Biopharma2022-04-15
Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS (NCT04849910)Vor Biopharma2021-12-16

Track Vor Biopharma automatically

Every clearance here is in the API, with alerts when new ones post.